- Home
- CTRM vs IBIO Comparison
CTRM vs IBIO Comparison
Compare CTRM & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTRM
- IBIO
- Stock Information
- Founded
- CTRM 2016
- IBIO 2008
- Country
- CTRM Cyprus
- IBIO United States
- Employees
- CTRM N/A
- IBIO N/A
- Industry
- CTRM Marine Transportation
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- CTRM Consumer Discretionary
- IBIO Health Care
- Exchange
- CTRM Nasdaq
- IBIO Nasdaq
- Market Cap
- CTRM 25.0M
- IBIO 24.3M
- IPO Year
- CTRM N/A
- IBIO N/A
- Fundamental
- Price
- CTRM $2.38
- IBIO $5.55
- Analyst Decision
- CTRM
- IBIO Strong Buy
- Analyst Count
- CTRM 0
- IBIO 3
- Target Price
- CTRM N/A
- IBIO $4.87
- AVG Volume (30 Days)
- CTRM 50.0K
- IBIO 843.9K
- Earning Date
- CTRM 03-18-2025
- IBIO 02-10-2025
- Dividend Yield
- CTRM N/A
- IBIO N/A
- EPS Growth
- CTRM N/A
- IBIO N/A
- EPS
- CTRM 2.39
- IBIO N/A
- Revenue
- CTRM $76,443,340.00
- IBIO $375,000.00
- Revenue This Year
- CTRM N/A
- IBIO $36.00
- Revenue Next Year
- CTRM N/A
- IBIO $33.33
- P/E Ratio
- CTRM $1.02
- IBIO N/A
- Revenue Growth
- CTRM N/A
- IBIO 650.00
- 52 Week Low
- CTRM $2.33
- IBIO $1.05
- 52 Week High
- CTRM $5.49
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- CTRM 40.22
- IBIO 62.10
- Support Level
- CTRM $2.37
- IBIO $5.23
- Resistance Level
- CTRM $2.84
- IBIO $5.85
- Average True Range (ATR)
- CTRM 0.15
- IBIO 0.77
- MACD
- CTRM 0.00
- IBIO 0.04
- Stochastic Oscillator
- CTRM 15.69
- IBIO 62.15
About CTRM Castor Maritime Inc.
Castor Maritime Inc is a provider of seaborne transportation services for dry bulk cargo, including iron ore, coal, grain, steel products, fertilizers, cement, bauxite, sugar, and scrap metal, among others. The firm operates under two reportable segments namely Dry bulk; Aframax/LR2 tanker; Handysize tanker and Container ship. It generates maximum revenue from the Dry bulk segment.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.